Arizona Tribune - CBD Life Sciences Inc. (CBDL) Reports 1,502.30% Revenue Increase from January to May 2025

SCOTTSDALE, AZ / ACCESS Newswire / June 11, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a rising player in the natural health and wellness space, is proud to report a 1,502.30% increase in revenue from January through May of 2025 - a historic milestone for the company and a clear reflection of its expanding presence across retail, digital, and direct-to-consumer channels.

This performance marks the company's strongest run of sustained month-over-month revenue growth to date and comes as CBDL shifts from a single-category CBD company to a diversified wellness brand with products designed for modern performance, recovery, and cognitive support.

"This isn't just about selling more products - it's about becoming a health brand that consumers actively seek out," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "We've laid the foundation for scalable, repeatable success by combining innovation, access, and a strong identity in functional wellness."

Key Drivers Of Growth

National Retail Expansion & E-Commerce Ubiquity
CBDL's ability to meet consumers where they shop has been a major growth catalyst in 2025. The brand has successfully launched and scaled across high-traffic digital and physical platforms, including:

• Walmart Marketplace: Multiple SKUs now available online, including CBDL's best-selling 3000MG Pain Relief Cream and skin care formulations.

• DoorDash & Leafly: Products are accessible via local delivery in select markets, offering speed and convenience for customers.

• Groupon: Strategic limited-time wellness deals driving strong first-time purchase activity and consumer discovery.

• Shopify & Reddit: Expanded direct-to-consumer operations through Shopify, complemented by engagement in Reddit's niche wellness communities to boost brand awareness and customer acquisition.

Product Innovation: Functional Wellness for the Modern Consumer

CBDL's revenue growth closely aligns with its rapid innovation across plant-powered health categories. Beyond CBD, the company is gaining traction with functional and adaptogenic wellness products, including:

• Mushroom Smoothies & Brain Support Blends: Featuring natural cognitive enhancers like lion's mane, reishi, and cordyceps, these smoothies support memory, mental clarity, and energy - and are appearing in local coffee shops and health stores.

• Power+ Sexual Enhancement Supplement: A plant-based formula supporting male vitality, stamina, and circulation, quickly becoming a customer favorite.

• Adaptogenic Mushroom Supplements: Proprietary blends designed to support immune health, stress reduction, and overall daily balance, harnessing reishi, chaga, lion's mane, and ashwagandha.

Strategic Vision & Responsible Growth

CBDL continues to invest in infrastructure, brand visibility, and strategic partnerships to ensure long-term sustainable growth. While focusing on the U.S. market currently, the company is evaluating future expansion opportunities and additional retail collaborations.

"Our focus remains on delivering real value through trusted products and accessible retail channels," added Nelson. "We are committed to building a wellness brand that serves consumers authentically while creating shareholder value."

About CBD Life Sciences Inc. (CBDL)

CBD Life Sciences Inc. is an Arizona-based health and wellness company focused on premium CBD, adaptogenic, and mushroom-based wellness products designed to support modern lifestyles. From pain relief to cognitive support and men's health, CBDL is committed to transparency, innovation, and accessibility.

Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: [email protected]

Stay Connected & Be the First to Try Our New Functional Mushroom Products!

Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
[email protected]
4802091720

SOURCE: CBD Life Sciences Inc.

View the original press release on ACCESS Newswire

O.Gutierrez--AT